![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
NEW APPROACHES IN THE MANAGEMENT OF METHICILLINRESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
*Shahnooshi Javad F and Anita Dadollahi Sarab
ABSTRACT Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs) are a growing issue worldwide with significant economic impact. As a pharmacist, you should be familiar with all the risk factors and treatment available now a day. A new antibiotic, tedizolid phosphate, appears to be a reasonable alternative to linezolid for the treatment of acute bacterial skin and skin structure infections (ABSSSI): A short (6-day) course of tedizolid phosphate was as effective as a 10-day course of linezolid with regard to both early and sustained clinical responses. Recently, new and unusual antibiotic compound has been extracted from a marine microorganism found in sediments off the coast of California, researcher also found that wearing gloves and gowns in intensive care units does not reduce overall rates of acquiring Methicillin-resistant Staphylococcus aureus (MRSA). Keywords: new approaches, methicillin-resistant staphylococcus aureus, management, antibiotic, prevention. [Download Article] [Download Certifiate] |